{"schema_version":"secwatch.filing_event.v1","accession":"0001770121-25-000009","form_type":"8-K","ticker":"SANA","cik":"0001770121","company_name":"Sana Biotechnology, Inc.","filed_at":"2025-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.934120+00:00","generated_at":"2026-05-17T15:36:09.084149+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Sana Biotechnology Q2 loss $0.39/sh (GAAP); positive type 1 diabetes cell therapy data; raises $105M","bullets":["Net loss $93.8M ($0.39/sh GAAP); non-GAAP net loss $38.9M ($0.16/sh) vs $74.2M ($0.32/sh) year ago.","Cash, cash equivalents & securities $72.7M at June 30; pro forma $177.2M including $105M raised in July/August 2025.","Six-month data show transplanted HIP-edited islet cells survive & function (C-peptide+) without immunosuppression; NEJM published 12-week results.","Expect to file IND for SC451 (iPSC-derived islet cell therapy) as early as 2026; FDA INTERACT meeting supports GMP master cell bank.","Enrolling GLEAM (SC291 in autoimmune) & VIVID (SC262 in B-cell malignancies); data expected 2025; IND for SG299 in vivo CAR T as early as 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001770121-25-000009","json":"https://secwatch.observer/filing/0001770121-25-000009.json","markdown":"https://secwatch.observer/filing/0001770121-25-000009.md","text":"https://secwatch.observer/filing/0001770121-25-000009.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770121/000177012125000009/0001770121-25-000009-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770121/000177012125000009/sana-20250811.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T15:36:09.084149+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}